Exosomes as Drug Carriers in Anti-Cancer Therapy

Over the years, there has been a high demand for developing new safe and effective drug carriers for cancer therapy. Emerging studies have indicated that exosomes can serve as potent therapeutic carriers since they offer low immunogenicity, high stability, innate and acquired targetability, and the stimulation of anti-cancer immune responses. Yet, the development of exosome-based drug delivery systems remains challenging due to their heterogeneity, low yield, and limited drug loading efficiency. Herein, we summarized the current application of exosomes derived from different cells as drug carriers in anti-cancer therapy in vitro and in vivo. We also discussed the challenges and prospects of exosome-based drug delivery systems in cancer therapy.

Automated summary

Exosomes as potential drug carriers in cancer therapy have attracted a high demand, but their development still faces challenges. This article summarizes the current applications of exosomes derived from different cells as drug carriers in anti-cancer therapy in vitro and in vivo, and discusses the challenges and prospects of exosome-based drug delivery systems in cancer therapy.